Bringing the very best science and medicine to our best equine friends

NEWS

Kindred Biosciences to Present Zimeta Pivotal Data at the 62nd Annual American Association of Equine Practitioners Convention

San Francisco, CA (November 29, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Emily Sundman, DVM, Clinical Development Scientist for KindredBio, will present pivotal effectiveness data for Zimeta™ (dipyrone injection) at the American Association of Equine Practitioners (AAEP) Convention in Orlando, FL on Tuesday, December 6, 2016 at 8:25 AM ET as part of the Internal Medicine track. The presentation will be available at http://kindredbio.com/investor-relations/events/ following the AAEP presentation. Zimeta is a pyrazolone anti-inflammatory drug with a unique mechanism of action that is under development for the …

Continue Reading

Kindred Biosciences to Present at 9th Annual LD Micro Investor Conference

San Francisco, CA (November 18, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Dr. Richard Chin, President and CEO, will be presenting at the 9th Annual LD Micro Investor Conference in Los Angeles, CA on Wednesday, December 7, 2016 at 1:30 PM PT. The conference is being held at the Luxe Sunset Boulevard Hotel. The presentation will be available via a live webcast at the following URL: http://wsw.com/webcast/ldmicro11/kin. An archived version of the webcast and presentation will be available for 30 days on the Company’s website: http://kindredbio.com/investor-relations/events. About …

Continue Reading

Kindred Biosciences Announces Third Quarter 2016 Financial Results

San Francisco, CA (November 7, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the third quarter ended September 30, 2016 and provided updates on its programs. “We are pleased with the progress across our programs as we execute our strategy of quickly and cost-effectively developing therapeutics for our animal family members. In support of the anticipated launch of Zimeta™ (dipyrone injection) and Mirataz™ (mirtazapine 2% ointment), we have been hiring key personnel, building our veterinary technical services and establishing distribution channels. The advances of our …

Continue Reading

Kindred Biosciences to Announce Third Quarter 2016 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Monday, November 7, 2016 San Francisco, CA (October 24, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its third quarter 2016 financial results on November 7, 2016 after the market close. The Company will host a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time that day. Interested parties may access the call by dialing toll-free (855) 433-0927 from the US, or (484) …

Continue Reading

Kindred Biosciences Receives Approval of Effectiveness Technical Section from FDA for Zimeta New Animal Drug Application

San Francisco, CA (October 4, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced it has received a technical section complete letter for effectiveness from the U.S. Food and Drug Administration’s Center for Veterinary Medicine for Zimeta™ (dipyrone injection) approving the technical section. The basis for this complete letter was a multicenter, randomized, blinded, placebo-controlled pivotal study that enrolled 138 horses to assess the effectiveness of Zimeta. The primary endpoint was improvement (a 2°F or greater decrease in temperature from baseline) or resolution of fever (a return to normothermia …

Continue Reading

KindredBio supports New Horizon Ranch – both working to strengthen the bond between horses and humans

KindredBio is a veterinary biopharmaceutical company based in Burlingame, CA that is focused on a strong development pipeline serving the horse with the motto “best medicines for our best friends.” KindredBio’s co-founder and many employees are horse people and advocates for the bond between horses and people with an understanding of how these animals change people’s lives. The value of the horse goes way beyond high end athletes such as our Olympic horses or Kentucky Derby winners.  Even retired or back yard horses touch human lives in unimaginable ways.  New Horizon ranch is a therapeutic riding center located in Rantoul, ...
Continue Reading

QH Kids in STEM Sign-Up Opens

QH Kids in STEM Sign-Up Opens Sponsored by Kindred Biosciences to encourage youth from quarter horse backgrounds to study and pursue careers in science, technology, engineering and mathematics. Indianola, IA: The GoodRide Group STEM Alliance and Kindred Biosciences (NASDAQ: KIN) are excited to announce that youth and parents from around the country can sign up to participate at no cost in QH Kids in STEM. “Inspire and engage is the goal for QH Kids in STEM digital series as the demand for skilled workers in science, technology, engineering and mathematics continues to rise,” cited Kris Moorman, founder of The GoodRide …

Continue Reading